Main > ONCOLOGY (**) > Lymphoma>HL>Classical> *** > Treatment > Co: USA. S. BrentuxiMAb Vedotin> > >After Failure auto-HSCT or>

after failure of at least two prior multi-agent CT regimens in patients who are not auto-HSCT candidates


>After Failure auto-HSCT or>'s products
This section has no products